Table 2.
Change Relative to Baseline | Subacute Phase Post-stroke (NORTHSTAR) | Chronic Phase Post-stroke (NORTHSTAR-CA) | Sham Chronic/Subacute Comparison | rTMS Chronic/Subacute Comparison | Stimulation x Phase (P values of Robust Median ANOVAs) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sham N = 19 | rTMS N = 20 | Post-hoc P value | Sham N = 14 | rTMS N = 14 | P value | P value | P value | Stimulation Main Effect | Phase Main Effect | Interaction Effect | |
Naming (BNT total correct Z-score) | |||||||||||
day 1 | .73 (.94) | .90 (1.19) | − | .21 (1.08) | .56 (1.69) | .706 | .839 | .727 | .406 | .170 | .455 |
day 30 | 1.02 (1.71) | 1.91 (.77) | rTMS>Sham (P = .046)* | .61 (1.00) | .15 (1.68) | .706 | .839 | .015* | .571 | .004* | <.001* |
Verbal fluency (SF1min Z-score) | |||||||||||
day 1 | .00 (.20) | .00 (.46) | − | .17 (1.95) | .26 (.71) | 1.000 | .839 | .103 | .845 | .320 | .634 |
day 30 | .73 (1.14) | .48 (.75) | − | .17 (.49) | .36 (.71) | .706 | .107 | .727 | .857 | .060 | .144 |
Comprehension (TT Z-score) | |||||||||||
day 1 | 1.12 (1.87) | .87 (1.99) | − | .35 (1.75) | .82 (2.10) | .706 | .02* | .727 | .836 | .423 | .430 |
day 30 | 2.07 (2.57) | 1.54 (2.22) | − | .93 (2.22) | .47 (2.16) | .706 | .364 | .145 | .351 | .036* | .735 |
UnAS (percent change) | |||||||||||
day 1 | 9.00 (19.9) | 6.85 (17.7) | − | 13.64 (46.60) | 9.39 (25.48) | .706 | .616 | .727 | .788 | .762 | .886 |
day 30 | 15.40 (63.5) | 26.25 (28.3) | − | 6.51 (56.44) | 12.53 (37.41) | .257 | .107 | .296 | .487 | .352 | .368 |
Post-treatment changes relative to baseline immediately after treatment (day 1), and at follow-up (day 30).
Medians (and interquartile ranges) are displayed for each subgroup as well as P values of median tests.
Significance level =.05.
BNT: Boston Naming Test; SF1min: semantic fluency test (animals in 1 minute); TT: 36-item Token Test; UnAS: unified aphasia score.
*Identifies P values <.05.